Leveraging pre-vaccination antibody titres across multiple influenza H3N2 variants to forecast the post-vaccination response
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (Rapid Reviews Infectious Diseases)
Abstract
No abstract available
